Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Voxilaprevir

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    China National Medical Products Administration Approves Vosevi
    China National Medical Products Administration Approves Vosevi

    20 Dec 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20191220005282/en

    BUSINESSWIRE
    20 Dec 2019
    Share Share
    FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier & Vosevi
    FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier & Vosevi

    29 Aug 2019

    // FDA

    https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and

    FDA
    29 Aug 2019
    Share Share
    FDA fires off a warning on rare cases involving death, adverse liver events
    FDA fires off a warning on rare cases involving death, adverse liver events

    29 Aug 2019

    // John Carroll ENDPTS

    https://endpts.com/fda-fires-off-a-warning-on-rare-cases-involving-death-adverse-liver-events-linked-to-misuse-of-3-big-hep-c-drugs/

    John Carroll ENDPTS
    29 Aug 2019
    Share Share
    FDA issues safety warning for newer hepatitis C drugs following patient deaths
    FDA issues safety warning for newer hepatitis C drugs following patient deaths

    28 Aug 2019

    // Jacob Bell BIOPHARMADIVE

    https://www.biopharmadive.com/news/fda-safety-warning-hepatitis-c-drugs-patient-deaths/561891/

    Jacob Bell BIOPHARMADIVE
    28 Aug 2019
    Share Share